Katalin Uri

Publications
Public outreach and news

Articles

Article: GEROSCIENCE. 2021;43(5):2289-2304
Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.
Fagyas M; Bánhegyi V; Úri K; Enyedi A; Lizanecz E; Mányiné IS; Mártha L; Fülöp GÁ; Radovits T; Pólos M; Merkely B; Kovács Á; Szilvássy Z; Ungvári Z; Édes I; Csanádi Z; Boczán J; Takács I; Szabó G; Balla J; Balla G; Seferovic P; Papp Z; Tóth A
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2016;17(4):1470320316668435
Circulating ACE2 activity correlates with cardiovascular disease development.
Úri K; Fagyas M; Kertész A; Borbély A; Jenei C; Bene O; Csanádi Z; Paulus WJ; Édes I; Papp Z; Tóth A; Lizanecz E
Article: PLOS ONE. 2014;9(4):e87845
New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.
Úri K; Fagyas M; Mányiné Siket I; Kertész A; Csanádi Z; Sándorfi G; Clemens M; Fedor R; Papp Z; Édes I; Tóth A; Lizanecz E
Article: PLOS ONE. 2014;9(4):e87844
New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
Fagyas M; Úri K; Siket IM; Fülöp GÁ; Csató V; Daragó A; Boczán J; Bányai E; Szentkirályi IE; Maros TM; Szerafin T; Édes I; Papp Z; Tóth A
Article: PLOS ONE. 2014;9(4):e87843
New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
Fagyas M; Úri K; Siket IM; Daragó A; Boczán J; Bányai E; Édes I; Papp Z; Tóth A
Article: PLOS ONE. 2014;9(4):e93719
New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.
Fagyas M; Úri K; Siket IM; Daragó A; Boczán J; Bányai E; Édes I; Papp Z; Tóth A

Articles

News from KI

Events from KI